{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:19:47Z","timestamp":1786573187874,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd008541.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000}}],"reference-count":84,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008541.pub3","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T05:07:26Z","timestamp":1461215246000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults"],"prefix":"10.1002","author":[{"given":"Simon","family":"Law","sequence":"additional","affiliation":[{"name":"Pain Relief Unit; The Churchill Hospital; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"issue":"13","key":"10.1002\/14651858.CD008541.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptan-naproxen for acute treatment of migraine: a randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0002|cit2","first-page":"53","article-title":"Two double-blind, multicentre, randomized, placebo-controlled, single-dose studies of sumatriptan\/naproxen sodium in the acute treatment of migraine: function, productivity and satisfaction outcomes","volume":"9","author":"Landy","year":"2007","journal-title":"Medscape General Medicine"},{"issue":"13","key":"10.1002\/14651858.CD008541.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","article-title":"Sumatriptan-naproxen for acute treatment of migraine: a randomized trial","volume":"297","author":"Brandes","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0004|cit4","first-page":"53","article-title":"Two double-blind, multicentre, randomized, placebo-controlled, single-dose studies of sumatriptan\/naproxen sodium in the acute treatment of migraine: function, productivity and satisfaction outcomes","volume":"9","author":"Landy","year":"2007","journal-title":"Medscape General Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3810\/pgm.2014.03.2743","article-title":"Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85\/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?","volume":"126","author":"Calhoun","year":"2014","journal-title":"Postgraduate Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/head.12214","article-title":"Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan\/naproxen sodium combination","volume":"54","author":"Landy","year":"2014","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD008541.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1468-2982.2008.01806.x","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a placebo-controlled, crossover study","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/head.12214","article-title":"Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan\/naproxen sodium combination","volume":"54","author":"Landy","year":"2014","journal-title":"Headache"},{"issue":"8","key":"10.1002\/14651858.CD008541.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1468-2982.2008.01806.x","article-title":"Consistency of response to sumatriptan\/naproxen sodium in a placebo-controlled, crossover study","volume":"29","author":"Lipton","year":"2009","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1526-4610.2011.01894.x","article-title":"Sumatriptan - naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes","volume":"51","author":"Cady","year":"2011","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jwh.2013.4577","article-title":"Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium","volume":"23","author":"Martin","year":"2014","journal-title":"Journal of Women's Health"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1526-4610.2011.01894.x","article-title":"Sumatriptan - naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes","volume":"51","author":"Cady","year":"2011","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","article-title":"Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials","volume":"114","author":"Mannix","year":"2009","journal-title":"Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jwh.2013.4577","article-title":"Relief of menstrual symptoms and migraine with a single-tablet formulation of sumatriptan and naproxen sodium","volume":"23","author":"Martin","year":"2014","journal-title":"Journal of Women's Health"},{"issue":"7","key":"10.1002\/14651858.CD008541.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1526-4610.2009.01458.x","article-title":"Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life","volume":"49","author":"Mathew","year":"2009","journal-title":"Headache"},{"issue":"7","key":"10.1002\/14651858.CD008541.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1526-4610.2009.01458.x","article-title":"Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life","volume":"49","author":"Mathew","year":"2009","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.wnl.0000316800.22949.20","article-title":"Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine","volume":"71","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0019|cit19","first-page":"195","article-title":"Sumatriptan\/naproxen sodium as early intervention for migraine: effects on functional ability, productivity, and satisfaction in 2 randomized controlled trials","volume":"14","author":"Taylor","year":"2007","journal-title":"Journal of Clinical Outcomes Management"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/01.wnl.0000316800.22949.20","article-title":"Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine","volume":"71","author":"Silberstein","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0021|cit21","first-page":"195","article-title":"Sumatriptan\/naproxen sodium as early intervention for migraine: effects on functional ability, productivity, and satisfaction in 2 randomized controlled trials","volume":"14","author":"Taylor","year":"2007","journal-title":"Journal of Clinical Outcomes Management"},{"issue":"8","key":"10.1002\/14651858.CD008541.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1526-4610.2005.05178.x","article-title":"Sumatriptan and naproxen sodium for the acute treatment of migraine","volume":"45","author":"Smith","year":"2005","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0023|cit23","unstructured":"A randomized, double-blind, double-dummy, placebo-controlled, crossover study to evaluate the efficacy of TREXIMET (sumatriptan + naproxen sodium) versus Butalbital-Containing Combination Medications (BCM) for the acute treatment of migraine when administered during the moderate-severe pain phase of the migraine (pooled data), 2010 download.gsk-clinicalstudyregister.com\/files\/21144.pdf"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1526-4610.2011.02039.x","article-title":"Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study","volume":"52","author":"Derosier","year":"2012","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/head.12211","article-title":"SumaRT\/nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study","volume":"54","author":"Cady","year":"2014","journal-title":"Headache"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/head.12052","article-title":"Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function","volume":"53","author":"Edwards","year":"2013","journal-title":"Headache"},{"issue":"2-B","key":"10.1002\/14651858.CD008541.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1590\/S0004-282X2000000300006","article-title":"Naproxen sodium decreases migraine recurrence when administered with sumatriptan","volume":"58","author":"Krymchantowski","year":"2000","journal-title":"Arquivos de Neuro-psiquiatria"},{"issue":"3","key":"10.1002\/14651858.CD008541.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1756285609102769","article-title":"Fixed-dose sumatriptan\/naproxen sodium compared with each monotherapy utilizing the novel composite endpoint of sustained pain-free\/no adverse events","volume":"2","author":"Landy","year":"2009","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1526-4610.2007.00790.x","article-title":"Sumatriptan\/naproxen sodium for migraine: efficacy, health related quality of life and satisfaction outcomes","volume":"47","author":"Smith","year":"2007","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0030|cit30","unstructured":"Glazo Smith Kline study register A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and tolerability of TREXIMET (sumatriptan 85mg and naproxen sodium 500mg) for a single moderate or severe headache in adults diagnosed with probable migraine without aura www.clinicaltrials.gov\/ct2\/show\/NCT00387881"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0333102413508242","article-title":"Sumatriptan\/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study","volume":"34","author":"Silberstein","year":"2014","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1002\/14651858.CD008541.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1751-7176.2011.00554.x","article-title":"Evaluation of the migraine treatment sumatriptan\/naproxen on blood pressure following long term administration","volume":"13","author":"White","year":"2011","journal-title":"Journal of Clinical Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0025-6196(11)60968-3","article-title":"Twelve month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine","volume":"82","author":"Winner","year":"2007","journal-title":"Mayo Clinic Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/0333102412438977","article-title":"The prevalence of primary headache disorders in Russia: a countrywide survey","volume":"32","author":"Ayzenberg","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0035|cit35","unstructured":"Naproxen for acute migraine, 2000 www.medicine.ox.ac.uk\/bandolier\/booth\/Migraine\/NapORacu.html"},{"issue":"8","key":"10.1002\/14651858.CD008541.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","article-title":"Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","article-title":"Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)","volume":"13","author":"Bloudek","year":"2012","journal-title":"Journal of Headache and Pain"},{"issue":"2-3","key":"10.1002\/14651858.CD008541.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0304-3959(00)00478-4","article-title":"Deconstructing migraine headache into peripheral and central sensitisation","volume":"89","author":"Burstein","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1526-4610.2011.02046.x","article-title":"Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"issue":"1-2","key":"10.1002\/14651858.CD008541.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3959(97)00005-5","article-title":"The visual analogue pain intensity scale: what is moderate pain in millimetres?","volume":"72","author":"Collins","year":"1997","journal-title":"Pain"},{"issue":"6977","key":"10.1002\/14651858.CD008541.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004234.pub3","article-title":"Single dose oral naproxen and naproxen sodium for acute postoperative pain in adults","author":"Derry","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008615.pub2","article-title":"Sumatriptan (oral route of administration) for acute migraine attacks in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008541.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1526-4610.2006.00631.x","article-title":"Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study","volume":"47","author":"Diamond","year":"2007","journal-title":"Headache"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD008541.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","article-title":"Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials","volume":"22","author":"Ferrari","year":"2002","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMra010917","article-title":"Migraine - current understanding and treatment","volume":"346","author":"Goadsby","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0048|cit48","unstructured":"http:\/\/www.goodrx.com\/triptan-nsaid-combinations http:\/\/www.goodrx.com\/triptan-nsaid-combinations"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1524-4733.2008.00404.x","article-title":"The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis","volume":"12","author":"Hazard","year":"2009","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0050|cit50","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0051|cit51","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","author":"Headache Classification Committee of the International Headache Society","year":"1988","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD008541.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"International Headache Society Clinical Trials Subcommittee","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1468-2982.2003.00824.x","article-title":"The International Classification of Headache Disorders: 2nd edition","volume":"24 Suppl 1","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD008541.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuroscience.2007.04.064","article-title":"Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion","volume":"148","author":"Jakubowski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/DDDT.S8410","article-title":"Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal","volume":"4","author":"Khoury","year":"2010","journal-title":"Drug Design, Development and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD008541.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009455","article-title":"Naproxen with or without an antiemetic for acute migraine headaches in adults","author":"Law","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008541.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10194-005-0252-4","article-title":"The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)","volume":"6","author":"Leonardi","year":"2005","journal-title":"Journal of Headache and Pain"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","article-title":"The cost of headache disorders in Europe: the Eurolight project","volume":"19","author":"Linde","year":"2012","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.1999.00006.x","article-title":"Acute migraine therapy: do doctors understand what patients with migraine want from therapy?","volume":"39 Suppl 2","author":"Lipton","year":"1999","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD008541.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1526-4610.2006.00430.x","article-title":"Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey","volume":"46","author":"Lucas","year":"2006","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD008541.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0066|cit66","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD008541.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD008541.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ejpain.2011.08.009","article-title":"A conservative method of testing whether combination analgesics produce additive or synergistic effects using evidence from acute pain and migraine","volume":"16","author":"Moore","year":"2012","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0071|cit71","first-page":"50","volume-title":"Statistics with Confidence - Confidence Intervals and Statistical Guidelines","author":"Morris","year":"1995"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1526-4610.2009.01369.x","article-title":"Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study","volume":"49","author":"Munakata","year":"2009","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0073|cit73","unstructured":"Palliative and Supportive Care Group PaPaS Author and Referee Guidance http:\/\/papas.cochrane.org\/papas-documents (accessed 19 November 2015)"},{"issue":"1","key":"10.1002\/14651858.CD008541.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1526-4610.2008.01263.x","article-title":"Prevalence and burden of headache and migraine in Germany","volume":"49","author":"Radtke","year":"2009","journal-title":"Headache"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0075|cit75","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","article-title":"Migraine: the seventh disabler","volume":"14","author":"Steiner","year":"2013","journal-title":"Journal of Headache and Pain"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10194-010-0217-0","article-title":"Prevalence of headache in Europe: a review for the Eurolight project","volume":"11","author":"Stovner","year":"2010","journal-title":"Journal of Headache and Pain"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5580\/6a2","article-title":"Efficacy and safety of sumatriptan plus naproxen sodium in the acute treatment of migraine: systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Suthisisang","year":"2011","journal-title":"Internet Journal of Pain, Symptom Control and Palliative Care"},{"issue":"7109","key":"10.1002\/14651858.CD008541.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/bmj.315.7109.635","article-title":"Impact of covert duplicate results on meta-analysis: a case study","volume":"315","author":"Tram\u00e8r","year":"1997","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD008541.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/0333102409355601","article-title":"Migraine prevalence by age and sex in the United States: a life-span study","volume":"30","author":"Victor","year":"2010","journal-title":"Cephalalgia"},{"issue":"9859","key":"10.1002\/14651858.CD008541.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008541.pub3-BIB0082|cit82","unstructured":"Sumatriptan\/naproxen sodium en.wikipedia.org\/wiki\/Sumatriptan\/naproxen_sodium"},{"issue":"4","key":"10.1002\/14651858.CD008541.pub3-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1526-4610.2011.02061.x","article-title":"The prevalence and burden of primary headaches in China: a population-based door-to-door survey","volume":"52","author":"Yu","year":"2012","journal-title":"Headache"},{"issue":"10","key":"10.1002\/14651858.CD008541.pub3-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008541.pub2","article-title":"Sumatriptan plus naproxen for acute migraine attacks in adults","author":"Law","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008541.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:21:19Z","timestamp":1628547679000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008541.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008541.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}